Global Health Results Analysis Q1FY26

Operating Revenue for Q1FY26 is Rs. 1,031 Crs., 19.7% growth YoY (The growth was primarily driven by increase in patient volumes and improved realization), Total Income is Rs. 1,051 Crs., 19% growth YoY, EBITDA is Rs. 255 Crs., 22.6% growth YoY, EBITDA Margin is 24.3% improved by 70 Basis points YoY, PBT Rs. 208 Crs., 44.9% growth YoY, PAT Rs. 159 Crs. 49.6% growth YoY. Occupied Bad Days were 142898 showing a growth of 13.3%, Avg. Rev. Per Op. Bed (ARPOB) Rs. 66,584 showing a growth of 4% (driven by increase in realization in Gurugram unit and change in speciality mix). During the period, International Patients Revenue increased by 33.8% YoY to INR 636 million, driven by increased international patient volume. On QoQ basis Op. Revenue is up by 10.7%, Total Income is up by 10.2%, EBITDA is flat to positive, PBT is up by 56% and PAT is also up by 56.8%. Total capex of over Rs. 40,000 million planned for next 5 years for 3,000 bed addition.